Semantic Scholar uses AI to extract papers important to this topic.
Objective To determine whether there is a link between hypoglycaemia and mortality among participants in the Action to Control… Expand BACKGROUND
Results of intervention studies in patients with type 2 diabetes have led to concerns about the safety of aiming for… Expand BACKGROUND
Rosiglitazone is an insulin sensitiser used in combination with metformin, a sulfonylurea, or both, for lowering blood… Expand Aim To compare the effects of combining liraglutide (0.6, 1.2 or 1.8 mg/day) or rosiglitazone 4 mg/day (all n ≥ 228) or placebo… Expand BACKGROUND
Exenatide is an incretin mimetic that shares glucoregulatory properties with glucagon-like peptide 1 (GLP-1), and… Expand Introduction and hypothesisDiabetes affects bone metabolism. The hypothesis was that type 1 (T1D) and type 2 (T2D) affects BMD… Expand BACKGROUND
Glucagon-like peptide 1 (GLP-1) has been proposed as a treatment for type 2 diabetes. We have investigated the long… Expand Abstract Objective: To examine the value of glycated haemoglobin (HbA1c) concentration, a marker of blood glucose concentration… Expand Hydroxyurea, a widely used cytotoxic/cytostatic agent that does not influence methylation of DNA bases, increases fetal… Expand